2017
DOI: 10.1016/j.vaccine.2017.05.024
|View full text |Cite
|
Sign up to set email alerts
|

Exploring evidence for behavioral risk compensation among participants in an HIV vaccine clinical trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 38 publications
0
3
0
Order By: Relevance
“…13,14 However, for other vaccines, evidence of risk compensation behaviours does exist. 15,16 A recent assessment of the impact of COVID-19 vaccination found no evidence of risk compensation behaviours, 17 whereas mask wearing is associated with greater risk taking. 18 In contrast, studies of risk compensation in relation to the management of animal health are rare.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…13,14 However, for other vaccines, evidence of risk compensation behaviours does exist. 15,16 A recent assessment of the impact of COVID-19 vaccination found no evidence of risk compensation behaviours, 17 whereas mask wearing is associated with greater risk taking. 18 In contrast, studies of risk compensation in relation to the management of animal health are rare.…”
Section: Introductionmentioning
confidence: 99%
“…Studies of human health have found no evidence of risk compensation following human papillomavirus vaccination 13,14 . However, for other vaccines, evidence of risk compensation behaviours does exist 15,16 . A recent assessment of the impact of COVID‐19 vaccination found no evidence of risk compensation behaviours, 17 whereas mask wearing is associated with greater risk taking 18 …”
Section: Introductionmentioning
confidence: 99%
“…4,5 This concern has been postulated for medical male circumcision, 6,7 microbicides, 5 pre-exposure prophylaxis (PrEP), [8][9][10][11] and vaccines. [12][13][14] Similarly, there has been concern that as HIV testing becomes normalised and the use of ART increases, sexual risk behaviour will increase. 4 Previous meta-analyses of individual-level risk compensation have looked at ART use and beliefs in Europe, Australia, and the USA after wide-scale ART roll-out 15 and, more recently, in sub-Saharan Africa.…”
Section: Introductionmentioning
confidence: 99%